Blue Jet Healthcare Limited (BLUEJET.NS)
INR 584.5
(1.93%)
INR 584.5
(1.93%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.37 Billion INR | 2.43% |
| 2022 | 1.96 Billion INR | -11.72% |
| 2021 | 2.22 Billion INR | 20.16% |
| 2020 | 1.85 Billion INR | -7.75% |
| 2019 | 2 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 648.71 Million INR | 59.07% |
| 2024 Q1 | 407.81 Million INR | -10.07% |
| 2023 Q2 | 561.56 Million INR | 6.82% |
| 2023 Q3 | 467.27 Million INR | -16.79% |
| 2023 Q1 | 525.69 Million INR | -16.57% |
| 2023 Q4 | 453.5 Million INR | -2.95% |
| 2023 FY | 2.01 Billion INR | 2.43% |
| 2022 Q1 | 327.14 Million INR | 0.0% |
| 2022 FY | 1.96 Billion INR | -11.72% |
| 2022 Q4 | 630.09 Million INR | 22.2% |
| 2022 Q3 | 515.63 Million INR | -1.84% |
| 2022 Q2 | 525.3 Million INR | 60.58% |
| 2021 FY | 2.22 Billion INR | 20.16% |
| 2020 FY | 1.85 Billion INR | -7.75% |
| 2019 FY | 2 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Biocon Limited | 50.83 Billion INR | 93.366% |
| Concord Biotech Limited | 6.26 Billion INR | 46.147% |
| Dishman Carbogen Amcis Limited | -413 Million INR | 916.518% |
| Jubilant Ingrevia Limited | 2.93 Billion INR | -14.703% |
| Lyka Labs Limited | 29.13 Million INR | -11476.45% |
| Panacea Biotec Limited | - INR | -Infinity% |
| Piramal Pharma Limited | 4.31 Billion INR | 21.851% |
| SMS Lifesciences India Limited | 359.47 Million INR | -838.104% |
| Supriya Lifescience Limited | 1.57 Billion INR | -114.566% |
| Syngene International Limited | 6.46 Billion INR | 47.863% |
| TAKE Solutions Limited | -213.49 Million INR | 1679.568% |
| Zota Health Care Limited | -129.79 Million INR | 2698.092% |